Merck Raises 2020 Adjusted EPS Guidance, Narrows Revenue Outlook, Lowers EPS Guidance
October 27 2020 - 07:52AM
Dow Jones News
By Dave Sebastian
Merck & Co. Inc. said it raised its adjusted-earnings
outlook and narrowed its revenue guidance for the full year, as it
continues to see strength in its underlying business, but it
lowered its earnings guidance as the company expects the pandemic
to weigh on some of its results.
The company said it expects adjusted earnings of $5.91 a share
to $6.01 a share on revenue of $47.6 billion to $48.6 billion. It
previously guided for adjusted earnings of $5.63 a share to $5.78 a
share on revenue of $47.2 billion to $48.7 billion.
Merck said it expects earnings of $4.55 a share to $4.65 a
share, compared with its prior outlook of $5.63 a share to $5.78 a
share. It expects operating expenses to be higher than the prior
year by a low-single-digit rate.
Merck said it expects the pandemic to hurt revenue by about
$2.35 billion, excluding foreign exchange. That would comprise
about $2.3 billion for pharmaceuticals and about $50 million for
animal health.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
October 27, 2020 07:37 ET (11:37 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2023 to Mar 2024